Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
32.60
-0.40 (-1.21%)
May 6, 2025, 11:43 AM EDT - Market open
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $18.79 billion as of May 6, 2025. Its market cap has increased by 50.84% in one year.
Market Cap
18.79B
Enterprise Value
25.42B
1-Year Change
50.84%
Ranking
Category
Stock Price
$32.60
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $18.79B, an increase of 19.23%. That is a compound annual growth rate of 3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2025 | 14.30B | 26.17% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |